secwatch.observer — SEC 8-K summary
======================================

Issuer:     Can B Corp (NASC)
CIK:        0001509957
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001493152-24-042714
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.01, 3.03, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Can B Corp. completes holding company reorganization; becomes subsidiary of Nascent Pharma Holdings
--------------------------------------------------------------------------------

- On Oct 25, 2024, Can B merged with Nascent Merger Sub, becoming wholly owned subsidiary of Nascent Pharma Holdings.
- Each share of Can B stock automatically converted into an equivalent corresponding share of Nascent stock with same rights.
- Reorganization conducted under FBCA Section 607.11045 without stockholder vote; no gain/loss for tax purposes.
- Can B filed Form 15 to deregister its shares; Nascent becomes successor issuer under Exchange Act.
- Nascent assumed Can B's 2021 Incentive Stock Option Plan and all outstanding stock options, converted on same terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509957/000149315224042714/0001493152-24-042714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509957/000149315224042714/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer